Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Solventum Corporation Common Stock (NY:SOLV)

68.95 +2.33 (+3.49%)
Streaming Delayed Price Updated: 9:59 AM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Solventum Corporation Common Stock

< Previous 1 2 3 4 Next >
Solventum (NYSE:SOLV) Exceeds Q1 Expectations
Healthcare solutions provider Solventum (NYSE:SOLV) announced better-than-expected revenue in Q1 CY2025, with sales up 2.7% year on year to $2.07 billion. Its non-GAAP profit of $1.34 per share was... 
Via StockStory
Earnings Scheduled For May 8, 2025
Via Benzinga
Wall Street Mixed Ahead Of Fed Meeting, Alphabet Sinks: What's Driving Markets Wednesday?
U.S. stocks traded mixed at midday Wednesday, as investors remained cautious ahead of the Federal Reserve’s upcoming policy decision, with Chair Jerome Powell set to speak at 2:30 p.m. ET. 
Via Benzinga
Topics Economy
Exposures Interest Rates
What Analysts Are Saying About Solventum Stock
Via Benzinga
Solventum Earnings: What To Look For From SOLV
Healthcare solutions provider Solventum (NYSE:SOLV) will be reporting earnings tomorrow after market close. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
7 Analysts Assess Solventum: What You Need To Know
Via Benzinga
3 Cash-Producing Stocks Walking a Fine Line
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
Alpha Buying: Big Oil Becomes Ground Zero for Activist Investing in 2025
Via Benzinga
Thermo Fisher Scientific Q1 Earnings Surpass Estimates, CEO Touts 'Strong Performance' Despite Economic Uncertainty
Thermo Fisher topped Q1 estimates with $5.15 EPS and $10.36 billion revenue, boosted by diagnostics and life sciences growth. 
Via Benzinga
Earnings Scheduled For February 27, 2025
Via Benzinga
Which S&P500 stocks have an unusual volume on Thursday?
Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below. 
Via Chartmill
Surgical Equipment & Consumables - Diversified Stocks Q4 Recap: Benchmarking STERIS (NYSE:STE)
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including STERIS... 
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
Reflecting On Surgical Equipment & Consumables - Diversified Stocks’ Q4 Earnings: Zimmer Biomet (NYSE:ZBH)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Zimmer Biomet (NYSE:ZBH) and the best and... 
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
3M Spin Off Solventum Targets Higher Margins, EPS Growth In 2025-2028 Strategy
Solventum detailed its 2025-2028 growth strategy, reaffirmed its 2025 guidance, and reported Q4 earnings that topped expectations with strong sales and EPS. 
Via Benzinga
Q4 Earnings Outperformers: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & Consumables - Diversified Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - diversified stocks fared... 
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
Solventum (SOLV): Buy, Sell, or Hold Post Q4 Earnings?
Solventum has been treading water for the past six months, recording a small return of 2.6% while holding steady at $74.01. 
Via StockStory
BD (NYSE:BDX): Strongest Q4 Results from the Surgical Equipment & Consumables - Diversified Group
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including BD (NYSE:BDX)... 
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
Here's What 3M's Big News Means to Investors
Via The Motley Fool
Surgical Equipment & Consumables - Diversified Stocks Q4 Highlights: CONMED (NYSE:CNMD)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at CONMED (NYSE:CNMD) and the best and worst... 
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
Is 3M Stock a Buy Now?
The manufacturing conglomerate is slowly turning a corner. 
Via The Motley Fool
Explore the top gainers and losers within the S&P500 index in today's session.
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Friday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
Why Solventum (SOLV) Stock Is Down Today
Shares of healthcare solutions provider Solventum (NYSE:SOLV) fell 6.5% in the morning session after the company reported weak fourth quarter results: its full-year EPS guidance missed. On the other... 
Via StockStory
Topics Initial Public Offering
Exposures Securities Market
Friday's session: top gainers and losers in the S&P500 index
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday. 
Via Chartmill
Which S&P500 stocks are gapping on Friday?
Curious about the S&P500 stocks that are gapping on Friday? Explore the gap up and gap down stocks in the S&P500 index during today's session. 
Via Chartmill
Friday's pre-market session: top gainers and losers in the S&P500 index
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. 
Via Chartmill
Solventum: Q4 EPS Beats, Cash Flow Dips
Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory pressures. 
Via The Motley Fool
Solventum’s (NYSE:SOLV) Q4 Sales Top Estimates
Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 1.9% year on year to $2.07 billion. Its non-GAAP profit of $1.41 per... 
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
Solventum (SOLV) Reports Q4: Everything You Need To Know Ahead Of Earnings
Healthcare solutions provider Solventum (NYSE:SOLV) will be reporting results tomorrow afternoon. Here’s what to look for. 
Via StockStory
Solventum Shares Are Up Today: What's Going On?
Solventum shares are trading higher Tuesday after the company announced it will sell its purification and filtration business to Thermo Fisher for $4.1 billion in cash. 
Via Benzinga
Which S&P500 stocks are moving on Tuesday?
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday. 
Via Chartmill
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.